Liu Shuang, Zhu Pengfei, Zhang Ling, Ding Shanlong, Zheng Sujun, Wang Yang, Lu Fengmin
Beijing Artificial Liver Treatment and Training Center, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Department of Microbiology and Infectious Disease Center, Peking University Health Science Center, Beijing, China.
Cancer Biomark. 2013;13(5):345-9. doi: 10.3233/CBM-130365.
Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) has been widely used to quantify relative gene expression because of the high specificity, sensitivity and accuracy of this technique. However, its reliability is strongly depends on the expression stability of reference gene used for data normalization. Therefore, identification of reliable and condition specific reference genes is critical for the success of RT-qPCR.
Hepatitis B virus (HBV) infection, male gender and the presence of cirrhosis are widely recognized as the leading independent risk factors for the development of hepatocellular carcinoma (HCC). This study aimed to select reliable reference gene for RT-qPCR analysis in HCC patients with all of those risk factors.
Six candidate reference genes were analyzed in 33 paired tumor and non-tumor tissues from untreated HCC patients. The genes expression stabilities were assessed by geNorm and NormFinder.
C-terminal binding protein 1(CTBP1) was the most stable gene among the 6 candidate genes evaluated by both geNorm and NormFinder. The expression stability values were 0.08 for CTBP1 and UBC, 0.09 for HPRT1, 0.12 for HMBS, 0.14 for GAPDH and 0.18 for 18S with geNorm analysis. The stability values suggested by NormFinder software were CTBP1: 0.044, UBC: 0.063, HMBS: 0.072, HPRT1: 0.072, GAPDH: 0.098 and 18S rRNA: 0.161.
This is the first systematic analysis which suggested CTBP1 as the highest expression-stable gene in human male HBV infection related-HCC with cirrhosis. We recommend CTBP1 as the best candidate reference gene when RT-qPCR was used to determine gene(s) expression in HCC. This may facilitate the relevant HBV related HCC studies in the future.
逆转录定量实时聚合酶链反应(RT-qPCR)因其高特异性、敏感性和准确性,已被广泛用于定量相对基因表达。然而,其可靠性很大程度上取决于用于数据标准化的内参基因的表达稳定性。因此,鉴定可靠的、条件特异性的内参基因对于RT-qPCR的成功至关重要。
乙型肝炎病毒(HBV)感染、男性性别和肝硬化的存在被广泛认为是肝细胞癌(HCC)发生的主要独立危险因素。本研究旨在为具有所有这些危险因素的HCC患者选择用于RT-qPCR分析的可靠内参基因。
对33例未经治疗的HCC患者的配对肿瘤组织和非肿瘤组织中的6个候选内参基因进行分析。通过geNorm和NormFinder评估基因表达稳定性。
在geNorm和NormFinder评估的6个候选基因中,C末端结合蛋白1(CTBP1)是最稳定的基因。geNorm分析中,CTBP1和泛素结合酶(UBC)的表达稳定性值为0.08,次黄嘌呤磷酸核糖转移酶1(HPRT1)为0.09,羟甲基胆色素合成酶(HMBS)为0.12,甘油醛-3-磷酸脱氢酶(GAPDH)为0.14,18S核糖体RNA(18S)为0.18。NormFinder软件给出的稳定性值为:CTBP1:0.044,UBC:0.063,HMBS:0.072,HPRT1:0.072,GAPDH:0.098,18S rRNA:0.161。
这是首次系统性分析,表明CTBP1是人类男性HBV感染相关肝硬化HCC中表达最稳定的基因。我们推荐在使用RT-qPCR测定HCC中的基因表达时,CTBP1作为最佳候选内参基因。这可能有助于未来相关的HBV相关HCC研究。